If the Medical Field were divided according to its industrial structure, it would probably look something like this:
First came the very top level:
Pharmaceutical companies, medical device companies, and government policies.
Then came the middle level:
Hospitals, all kinds of related medical institutions, and drug/medical device distributors connecting the first two with the upstream sector.
Finally came the grassroots level at the bottom:
Doctors and patients.
Within such an industrial structure, the upstream industries held enormous influence.
Whether it was the successful development of a new drug targeting leukemia, a technological innovation in clinical equipment, or a national policy that lowered the price of Cardiac Stents from tens of thousands to a few hundred,
every upstream industry could have a massive impact on the middle- and lower-level industries connected to it.
With two multinational giants under its name, one in pharmaceuticals and the other in medical devices, as well as being one of the influential members of numerous public medical organizations, its cooperation network spanned the globe.
Sanatoriums, charitable healthcare, medical distribution companies, and countless other industries, along with hundreds of private hospitals across the United States and contracts with more than a hundred thousand doctors—
this was Fies Erde's territory in the Medical Field.
And at the heart of that territory, the core supporting the entire healthcare service system,
were doctors and medical institutions such as hospitals.
After all, this field had originated because sick people needed to go to hospitals and see doctors.
Once that central pillar was shaken, the entire healthcare service industry would be shaken along with it.
And a crucial factor sustaining doctors and foundational medical institutions such as hospitals was the commercial health insurance companies jointly established through cooperation between the Medical Field and the insurance sector.
As for why, that required an